The Na­tional In­sti­tutes of Health has halted op­er­a­tions at one of its drug man­u­fac­tur­ing fa­cil­i­ties af­ter fun­gus was dis­cov­ered in two vials of a blood pro­tein used for ex­per­i­men­tal stud­ies.

Modern Healthcare - - LATE NEWS -

Of­fi­cials said none of the pa­tients given the blood pro­tein have shown signs of in­fec­tion or ill­ness, and all have been no­ti­fied and are be­ing mon­i­tored. Con­tam­i­nated vials of the blood pro­tein al­bu­min were dis­cov­ered in April af­ter a com­plaint was made to the Food and Drug Ad­min­is­tra­tion. A sub­se­quent FDA in­spec­tion found a num­ber of “se­ri­ous man­u­fac­tur­ing prob­lems,” in­clud­ing fail­ures to fol­low stan­dard op­er­at­ing pro­ce­dures.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.